Kalergis AM - Search Results

1

Point mutations in the beta chain CDR3 can alter the T cell receptor recognition pattern on an MHC class I/peptide complex over a broad interface area.

Goyarts EC, Vegh Z, Kalergis AM, Hörig H, Papadopoulos NJ, Young AC, Thomson CT, Chang HC, Joyce S, Nathenson SG. Goyarts EC, et al. Among authors: kalergis am. Mol Immunol. 1998 Jul;35(10):593-607. doi: 10.1016/s0161-5890(98)00056-x. Mol Immunol. 1998. PMID: 9823758

2

On defining the rules for interactions between the T cell receptor and its ligand: a critical role for a specific amino acid residue of the T cell receptor beta chain.

Wang F, Ono T, Kalergis AM, Zhang W, DiLorenzo TP, Lim K, Nathenson SG. Wang F, et al. Among authors: kalergis am. Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5217-22. doi: 10.1073/pnas.95.9.5217. Proc Natl Acad Sci U S A. 1998. PMID: 9560256 Free PMC article.

3

Alterations in TCR-MHC contacts subsequent to cross-recognition of class I MHC and singly substituted peptide variants.

Ono T, DiLorenzo TP, Wang F, Kalergis AM, Nathenson SG. Ono T, et al. Among authors: kalergis am. J Immunol. 1998 Nov 15;161(10):5454-63. J Immunol. 1998. PMID: 9820521

4

Single amino acid replacements in an antigenic peptide are sufficient to alter the TCR V beta repertoire of the responding CD8+ cytotoxic lymphocyte population.

Kalergis AM, Ono T, Wang F, DiLorenzo TP, Honda S, Nathenson SG. Kalergis AM, et al. J Immunol. 1999 Jun 15;162(12):7263-70. J Immunol. 1999. PMID: 10358174

5

A simplified procedure for the preparation of MHC/peptide tetramers: chemical biotinylation of an unpaired cysteine engineered at the C-terminus of MHC-I.

Kalergis AM, Goyarts EC, Palmieri E, Honda S, Zhang W, Nathenson SG. Kalergis AM, et al. J Immunol Methods. 2000 Feb 3;234(1-2):61-70. doi: 10.1016/s0022-1759(99)00215-x. J Immunol Methods. 2000. PMID: 10669770

6

Altered peptide ligand-mediated TCR antagonism can be modulated by a change in a single amino acid residue within the CDR3 beta of an MHC class I-restricted TCR.

Kalergis AM, Nathenson SG. Kalergis AM, et al. J Immunol. 2000 Jul 1;165(1):280-5. doi: 10.4049/jimmunol.165.1.280. J Immunol. 2000. PMID: 10861062

7

Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex.

Kalergis AM, Boucheron N, Doucey MA, Palmieri E, Goyarts EC, Vegh Z, Luescher IF, Nathenson SG. Kalergis AM, et al. Nat Immunol. 2001 Mar;2(3):229-34. doi: 10.1038/85286. Nat Immunol. 2001. PMID: 11224522

8

A structural difference limited to one residue of the antigenic peptide can profoundly alter the biological outcome of the TCR-peptide/MHC class I interaction.

Thomson CT, Kalergis AM, Sacchettini JC, Nathenson SG. Thomson CT, et al. Among authors: kalergis am. J Immunol. 2001 Mar 15;166(6):3994-7. doi: 10.4049/jimmunol.166.6.3994. J Immunol. 2001. PMID: 11238645

9

The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation.

Reddy B, Gupta S, Chuzhin Y, Kalergis AM, Budhai L, Zhang M, Droguett G, Horwitz MS, Chowdhury JR, Nathenson SG, Davidson A. Reddy B, et al. Among authors: kalergis am. Transplantation. 2001 Mar 27;71(6):801-11. doi: 10.1097/00007890-200103270-00020. Transplantation. 2001. PMID: 11330546

10

Hapten addition to an MHC class I-binding peptide causes substantial adjustments of the TCR structure of the responding CD8(+) T cells.

Honda S, Zhang W, Kalergis AM, DiLorenzo TP, Wang F, Nathenson SG. Honda S, et al. Among authors: kalergis am. J Immunol. 2001 Oct 15;167(8):4276-85. doi: 10.4049/jimmunol.167.8.4276. J Immunol. 2001. PMID: 11591750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters